153 Diagnostic utility of molecular and imaging biomarkers 2 Figure 27. SROC curve of BRAF/RAS mutation analysis – Bethesda III Summary receiver operating characteristic plot showing sensitivity versus 1-specificity of BRAF/RAS mutation analysis in Bethesda III thyroid nodules with available histopathology. AUC = 0.88 (95% CI: 0.85-0.91). AUC, area under the curve; HSROC, hierarchical summary receiver operating characteristic. Figure 29. SROC curve of BRAF/RAS mutation analysis – Bethesda IV Summary receiver operating characteristic plot showing sensitivity versus 1-specificity of BRAF/RAS mutation analysis in Bethesda IV thyroid nodules with available histopathology. AUC = 0.88 (95% CI: 0.85-0.91). AUC, area under the curve; HSROC, hierarchical summary receiver operating characteristic.
RkJQdWJsaXNoZXIy MTk4NDMw